136584-14-0 Usage
Uses
Used in Pharmaceutical Industry:
1,2,3,4-TETRAHYDRO-3-OXO-2-QUINOXALINEACETIC ACID is used as a neuroprotective agent for its potential therapeutic effects in treating Alzheimer's disease and other neurodegenerative disorders. Its antioxidant and anti-inflammatory properties contribute to its potential as a treatment option, particularly due to its ability to inhibit the production of amyloid beta, a key protein associated with Alzheimer's disease.
Used in Research and Development:
1,2,3,4-TETRAHYDRO-3-OXO-2-QUINOXALINEACETIC ACID is utilized in ongoing research to further explore its potential as a therapeutic agent for neurological conditions. Its antioxidant and anti-inflammatory properties, along with its capacity to inhibit amyloid beta production, make it a valuable compound for scientific investigation into the prevention and treatment of neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 136584-14-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,5,8 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 136584-14:
(8*1)+(7*3)+(6*6)+(5*5)+(4*8)+(3*4)+(2*1)+(1*4)=140
140 % 10 = 0
So 136584-14-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H10N2O3/c13-9(14)5-8-10(15)12-7-4-2-1-3-6(7)11-8/h1-4,8,11H,5H2,(H,12,15)(H,13,14)/p-1/t8-/m1/s1
136584-14-0Relevant articles and documents
SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS
-
Page/Page column 115, (2010/02/07)
Disclosed are sulfonylquinoxalone acetamide derivatives useful as bradykinin antagonists to relieve symptons, associated with bradykinin including pain, inflammation, bronchoconstriction, cerebral edema, etc.
Quinoxalines, processes for their preparation and their use
-
, (2008/06/13)
Compounds of the formula I or Ia in which n and the substituents R1, R5and x have the meaning mentioned have an antiviral activity.